The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Associations of insulin-like growth factor binding proteins and adiponectin with disease progression and mortality in metastatic colorectal cancer: Results from CALGB/SWOG 80405 (Alliance).
 
Brendan John Guercio
No Relationships to Disclose
 
Alan P. Venook
Consulting or Advisory Role - Bayer; Eisai; Halozyme; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bayer; Genentech; Halozyme; Roche
 
Sui Zhang
No Relationships to Disclose
 
Fang-Shu Ou
No Relationships to Disclose
 
Donna Niedzwiecki
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Federico Innocenti
Patents, Royalties, Other Intellectual Property - Royalties from the Mayo Foundation on the UGT1A1 testing
 
Michael N. Pollak
Stock and Other Ownership Interests - Immunome
Honoraria - Fusion Pharmaceuticals
Consulting or Advisory Role - Fusion Pharmaceuticals
 
Andrew B. Nixon
Consulting or Advisory Role - Kanghong Pharma; Lilly; Pfizer
Research Funding - Acceleron Pharma; Amgen; AstraZeneca/MedImmune; Eureka Therapeutics; Genentech/Roche; Leadiant Biosciences; medpacto; Novartis; Seagen; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Michelle R. Mahoney
No Relationships to Disclose
 
Bert O'Neil
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; Merck
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Bayer; Merck KGaA
 
James Edward Shaw
No Relationships to Disclose
 
Blase N. Polite
Research Funding - Merck
Other Relationship - Gerson Lehrman Group
 
Crystal S. Denlinger
Honoraria - Dava Oncology
Consulting or Advisory Role - Bayer; BeiGene; Bristol-Myers Squibb; Lilly; Merck
Research Funding - Advaxis (Inst); Agios (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Merrimack (Inst); OncoMed (Inst)
 
James Norman Atkins
No Relationships to Disclose
 
Richard M. Goldberg
Consulting or Advisory Role - Merck; Merck KGaA; Novartis; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Merck; Merck KGaA
 
Robert J. Mayer
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - CASI Pharmaceuticals
 
Charles David Blanke
No Relationships to Disclose
 
Charles S. Fuchs
Leadership - CytomX Therapeutics
Stock and Other Ownership Interests - CytomX Therapeutics; Entrinsic Health
Consulting or Advisory Role - Agios; Bain Capital; Bayer; Celgene; CytomX Therapeutics; Dicerna; Entrinsic Health; Five Prime Therapeutics; Genentech/Roche; Gilead Sciences; KEW; Lilly; Merck; Merrimack; Pfizer; Sanofi; Taiho Pharmaceutical; Unum Therapeutics
 
Jeffrey A. Meyerhardt
Honoraria - Chugai Pharma; Cota Healthcare; Ignyta; Taiho Pharmaceutical
Research Funding - Boston Biomedical (Inst)